- Home
- GERN vs MPB Comparison
GERN vs MPB Comparison
Compare GERN & MPB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GERN | MPB |
|---|---|---|
| Founded | 1990 | 1868 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 900.1M | 738.9M |
| IPO Year | 1996 | N/A |
Fundamental Metrics
Financial Performance| Metric | GERN | MPB |
|---|---|---|
| Price | $1.62 | $34.02 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 7 | 1 |
| Target Price | $3.00 | ★ $37.00 |
| AVG Volume (30 Days) | ★ 13.8M | 126.5K |
| Earning Date | 02-25-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.56% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.40 |
| Revenue | $183,403,000.00 | ★ $208,869,000.00 |
| Revenue This Year | $146.80 | $27.55 |
| Revenue Next Year | $30.21 | $29.71 |
| P/E Ratio | ★ N/A | $14.31 |
| Revenue Growth | ★ 522.13 | 20.73 |
| 52 Week Low | $1.04 | $22.50 |
| 52 Week High | $2.96 | $35.22 |
Technical Indicators
Market Signals| Indicator | GERN | MPB |
|---|---|---|
| Relative Strength Index (RSI) | 68.06 | 60.71 |
| Support Level | $1.45 | $34.26 |
| Resistance Level | $1.58 | $34.97 |
| Average True Range (ATR) | 0.09 | 0.97 |
| MACD | 0.02 | 0.12 |
| Stochastic Oscillator | 97.10 | 72.35 |
Price Performance
Historical ComparisonAbout GERN Geron Corporation
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.
About MPB Mid Penn Bancorp
Mid Penn Bancorp Inc operates in the financial services domain. It conducts commercial banking and trust business in the United States. Its range of services comprises mortgage and home equity loans, secured and unsecured consists and consumer loans, lines of credit, construction financing, farm loans, community development, local government loans, and various types of time and demand deposits.